Omeros (OMER) EBT Margin Growth (3y) (2013 - 2022)
Omeros (OMER) EBT Margin Growth (3y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -18,378.00 |
| Mar 31, 2022 | -46,514.00 |
| Dec 31, 2021 | 19,721.00 |
| Sep 30, 2021 | 361,196.00 |
| Jun 30, 2021 | 630,419.00 |
| Mar 31, 2021 | 167,803.00 |
| Dec 31, 2020 | -64,712.00 |
| Sep 30, 2020 | 36,443.00 |
| Jun 30, 2020 | 30,881.00 |
| Mar 31, 2020 | 45,310.00 |
| Dec 31, 2019 | -22,392.00 |
| Sep 30, 2019 | 28,819.00 |
| Jun 30, 2019 | 11,697.00 |
| Mar 31, 2019 | 103,398.00 |
| Dec 31, 2018 | 23,608.00 |
| Sep 30, 2018 | -220,076.00 |
| Jun 30, 2018 | -338,372.00 |
| Mar 31, 2018 | 3.36 Mn |
| Dec 31, 2017 | 1.19 Mn |
| Sep 30, 2017 | 2.75 Mn |